Childhood epilepsy remains a growing global health concern, with an increasing incidence despite ongoing declines in mortality and DALYs. Although advancements in healthcare have contributed to reduced epilepsy-related deaths and DALYs over time, the absolute burden of this neurological disorder remains substantial, particularly in pediatric populations, with significant regional differences. These findings underscore the urgent need to enhance early screening programs and improve the accessibility of antiepileptic medications, especially in low SDI regions.